Advisors Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $554K | Sell |
7,934
-228
| -3% | -$15.9K | 0.01% | 357 |
|
|
2025
Q1 | $600K | Buy |
8,162
+245
| +3% | +$18K | 0.01% | 337 |
|
|
2024
Q4 | $519K | Sell |
7,917
-1,421
| -15% | -$93.1K | 0.01% | 368 |
|
|
2024
Q3 | $728K | Buy |
9,338
+721
| +8% | +$56.2K | 0.01% | 325 |
|
|
2024
Q2 | $672K | Sell |
8,617
-31
| -0.4% | -$2.42K | 0.01% | 325 |
|
|
2024
Q1 | $586K | Buy |
8,648
+433
| +5% | +$29.3K | 0.01% | 341 |
|
|
2023
Q4 | $553K | Buy |
+8,215
| New | +$553K | 0.01% | 339 |
|
|
2023
Q3 | – | Sell |
-6,086
| Closed | -$436K | – | 414 |
|
|
2023
Q2 | $436K | Buy |
6,086
+133
| +2% | +$9.53K | 0.01% | 330 |
|
|
2023
Q1 | $413K | Sell |
5,953
-420
| -7% | -$29.1K | 0.01% | 326 |
|
|
2022
Q4 | $432K | Sell |
6,373
-804
| -11% | -$54.5K | 0.01% | 326 |
|
|
2022
Q3 | $459K | Buy |
+7,177
| New | +$459K | 0.01% | 327 |
|